dehydroepiandrosterone has been researched along with osteoprotegerin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, J; Evans, B; Hampson, G; Harding, G; MacDonald, D; Mak, YT | 1 |
| McCormick, RK | 1 |
| Cheng, WW; Tao, MF; Wan, XP; Wang, L; Wang, YD | 1 |
| Cheng, WW; Cui, K; Liu, XH; Tao, MF; Wan, XP; Wang, YD | 1 |
| Ostrowska, Z; Oświęcimska, J; Swiętochowska, E; Wołkowska-Pokrywa, K; Ziora, K | 1 |
1 review(s) available for dehydroepiandrosterone and osteoprotegerin
| Article | Year |
|---|---|
Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility.
Topics: Absorptiometry, Photon; Acidosis; Biomarkers; Bone Density; Bone Remodeling; C-Reactive Protein; Calcium; Celiac Disease; Dehydroepiandrosterone; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hyperhomocysteinemia; Male; Osteoporosis; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Thyroid Diseases; Vitamin D; Vitamin K | 2007 |
4 other study(ies) available for dehydroepiandrosterone and osteoprotegerin
| Article | Year |
|---|---|
The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA.
Topics: Androstenedione; Cell Line; Cytokines; Dehydroepiandrosterone; Dexamethasone; Gene Expression Profiling; Gene Expression Regulation; Humans; Oligonucleotide Array Sequence Analysis; Osteoclasts; Osteoprotegerin; RANK Ligand; Receptors, Cytokine; RNA, Messenger; Vascular Endothelial Growth Factor A | 2006 |
Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway.
Topics: Apoptosis; Cell Line; Cell Proliferation; Dehydroepiandrosterone; Enzyme Activation; Estrogen Receptor alpha; Estrogen Receptor beta; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Gene Silencing; Humans; MAP Kinase Signaling System; Osteoblasts; Osteoprotegerin; RANK Ligand; RNA, Messenger | 2012 |
Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway.
Topics: Apoptosis; Butadienes; Cell Proliferation; Cells, Cultured; Dehydroepiandrosterone; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoblotting; Mitogen-Activated Protein Kinases; Nitriles; Osteoblasts; Osteoclasts; Osteoprotegerin; RANK Ligand; Signal Transduction | 2012 |
Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa.
Topics: Adolescent; Anorexia Nervosa; Biomarkers; Bone and Bones; Collagen Type I; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Osteocalcin; Osteoprotegerin; RANK Ligand; Reference Values | 2012 |